ArticleAnnals of the American Thoracic Society2024

OPTIMA: An Open-Label, Noncomparative Pilot Trial of Inhaled Molgramostim in Pulmonary Nontuberculous Mycobacterial Infection.

Rachel M Thomson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.